Daily TIP

The Daily TIP: Iran Falsely Claims That New U.S. Sanctions Violate Nuclear Deal

Posted by Tip Staff - August 02, 2017

Iran Falsely Claims That New U.S. Sanctions Violate Nuclear Deal
NYTimes Editor: Progressive Left Damages Itself by Embracing Anti-Semites, Illiberal Causes
Footage Released of Palestinian Stabbing Attack That Left Israeli Man Critically Injured
Hebrew U Scientist Develops Technology That Could Reduce Need for Animal Testing


Iran Falsely Claims That New U.S. Sanctions Violate Nuclear Deal

Iran is claiming that recent sanctions imposed on its ballistic missile program by the United States violate the 2015 nuclear deal, even though the administration of former President Barack Obama stressed that the accord only freed Iran from nuclear-related sanctions, Reuters reported Tuesday.

Ali Larijani, speaker of Iran’s parliament told Tasnim News that the newly imposed sanctions violated the nuclear deal, and that Iran would take its complaint to the commission that monitors compliance with the deal, which is formally known as the Joint Comprehensive Plan of Actions (JCPOA).

On Friday, the United States Treasury Department designated six Iranian entities for their role in supporting Iran's ballistic missile program. President Donald Trump signed a bill sanctioning Russia, North Korea and Iran into law on Wednesday.

Contrary to Iranian objections over the new sanctions, at a Senate hearing in July 2015, then Secretary of State John Kerry was emphatic that Iran agreed that the nuclear deal would not bar Washington from imposing and maintaining non-nuclear sanctions against it.

According to the Corker-Cardin bill, which passed in May 2015, the president has to certify Iran's compliance with the nuclear deal and "any related agreements" every 90 days. United Nations Security Council Resolution 2231, which codified the JCPOA, called on Iran "not to undertake any activity related to ballistic missiles designed to be capable of delivering nuclear weapons, including launches." State Department spokesperson Heather Nauert stated last week that the U.S. considered Iran's ballistic missile launches to be "a violation of UNSCR 2231."



NYTimes Editor: Progressive Left Damages Itself by Embracing Anti-Semites, Illiberal Causes

The progressive Left is failing to confront hate in their own ranks by embracing activists with a long history of illiberal rhetoric and views, among them Linda Sarsour, who served as one of the four national co-chairs of the Women’s March on Washington.

“Will progressives have more spine than conservatives in policing hate in their ranks? Or will they ignore it in their fury over the Trump administration?,” staff editor Bari Weiss asked in an opinion piece published in The New York Times on Tuesday.

“Nothing is creepier than Zionism,” Sarsour wrote in 2012, one of the numerous controversial statements made by the Palestinian activist that Weiss references as evidence that Sarsour is a bigot in progressive clothing.

The picture that emerges is that of anything but a feminist and defender of human rights. “You’ll know when you’re living under Shariah law if suddenly all your loans and credit cards become interest-free. Sound nice, doesn’t it?” Sarsour claimed. At the same time, Weiss wrote, that Sarsour showed little regard for victims of Islamic extremism, when she attacked “the anti-Islamist feminist Ayaan Hirsi Ali in the most crude and cruel terms, insisting she is ‘not a real woman.’”

“Maybe I’ll be accused of siding with the alt-right or tarred as Islamophobic. But what I stand against is embracing terrorists, disdaining independent feminist voices, hating on democracies and celebrating dictatorships,” Weiss concluded. “If that puts me beyond the pale of the progressive feminist movement in America right now, so be it.”



Footage Released of Palestinian Stabbing Attack That Left Israeli Man Critically Injured

Authorities have released footage showing a Palestinian terrorist stabbing and critically wounding a supermarket employee in the central Israeli city of Yavneh on Wednesday.

The unnamed 43-year-old victim is seen fighting off his 19-year-old attacker, Ismail Ibrahim Ismail Abu Aram, despite sustaining stab wounds to the head, neck, and upper body, The Times of Israel reported. The victim was rushed to the Kaplan Medical Center in Rehovot in unstable condition.

Abu Aram tried to flee the scene but was tackled and held down by civilian bystanders until police arrived. Though he had no record of previous terrorist activity, he was subsequently transferred to the Shin Bet for further interrogation.

Abu Aram entered Israel illegally from his hometown of Yatta, near Hebron in the West Bank. Israeli forces searched his house following the attack, but made no arrests.

A number of recent terrorists came from Yatta, including the two Palestinian gunmen who carried out the lethal Sarona Market attack in June 2016.

According to Israeli authorities, over 50 people have been killed in Palestinian terrorist attacks---including shootings, stabbings, and car rammings---since September 2015. The Israeli Ministry of Foreign Affairs blames the wave of terror on "incitement by radical Islamist and terrorist elements, calling on Palestinian youth to murder Jews."

"Statements by Fatah, Hamas and [Palestinian Islamic Jihad] spokespersons have described the attacks as 'heroic actions' and 'the natural response to Israel's crimes,'" the ministry added.



Hebrew U Scientist Develops Technology That Could Reduce Need for Animal Testing

After spending an average of $2.5 billion to develop a single new drug, sometimes pharma companies have to pull it from the market due to a bad outcome that was not detected in clinical studies.

That’s what happened in 2000, when a promising Type 2 diabetes drug called troglitazone led to idiosyncratic (unexplained) liver damage in one of every 60,000 users.

The troglitazone mystery wasn’t solved until March 2016, when a novel “liver-on-a-chip” platform developed by Hebrew University of Jerusalem Prof. Yaakov Nahmias revealed what no animal or human tests could: even low concentrations of this drug caused liver stress before any damage could be seen.

Given that about 16 percent of all FDA-approved drugs eventually show unexpected toxicity, Nahmias recognized the potential of his smart human-on-a-chip platform.

He licensed the technology from the university and spun off Tissue Dynamics to provide toxicology analysis of drugs and cosmetics.

“However, we can probably drastically reduce the number of animal experiments,” Nahmais said. “We could screen half a million different drug molecules through our system, and only those that work at the least concentration and cause the least damage could be taken to animal testing.”

Nahmias is chief scientific officer of Tissue Dynamics, whose six-person staff includes CEO Ayelet Dilion Mashiah. He also directs the Alexander Grass Center for Bioengineering at the Hebrew University and won several prizes for his internationally recognized work in tissue engineering and nanotechnology.

(via Israel21c)


Be the first to comment

Please check your e-mail for a link to activate your account.